ACD Seminar Series
RNAscope® Technology

Monday May 22, 2017


Ludwig Cancer Research, Oxford University, UK

 

Complete this form to register


RNASCOPE® & BASESCOPE TECHNOLOGY

IN CANCER RESEARCH

Monday May 22, 2017

11:30 to 12:30 

Seminar Room | Old Campus Research Building | Roosevelt Drive 


Ludwig Institute for Cancer Research, Oxford University
Oxford, UK


 

The RNAscope® technology is being routinely used for tissue-based gene expression analysis for cancer research applications. In particular, the ultra-high sensitivity and specificity enables researchers to examine tumor heterogeneity within the tumor and in the tumor micro-environment. This technology, with its capacity to provide single-cell and single-RNA molecule sensitivity in the context of the tumor, has advanced cancer research and has been applied in over 800 publications.

 

Faraia Shah will present an overview on:

Visualizing gene expression and genetic variations in cancer research using RNAscope® and BaseScope™ Assays

  • Detect mRNAs and lncRNAs at single molecule sensitivity by RNAscope® assay
  • Target specific splice junctions for aberrant alternative splicing in cancers by BaseScope™ assay
  • Characterize expression profiles of various cancer markers in tumors and micro-environment
  • Case studies with PDL1, EGFR and other cancer markers will be discussed. 

Speakers

Faraia Shah MPhil, PhD

FShah@acdbio.com
Sales Account Executive
Advanced Cell Diagnostics 

Marcus Green, PhD

 

Space is limited.  Cakes and buns will be provided so please register for headcount.